Dow Up0.08% Nasdaq Down0.30%

More On SUNPHARMA.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

-NSE
807.15 Up 2.10(0.26%) Sep 19, 5:59AM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Mar 31, 2013Mar 31, 2012Mar 31, 2011
Total Revenue 160,804,000   112,999,000   80,195,000   57,279,000  
Cost of Revenue38,256,000  28,819,000  22,559,000  18,956,000  
Gross Profit 122,548,000   84,180,000   57,636,000   38,323,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses92,695,000  64,046,000  50,083,000  39,621,000  
Operating Income or Loss 68,109,000   48,953,000   30,112,000   17,658,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes68,109,000  48,953,000  30,112,000  17,658,000  
Interest Expense(224,000)(369,000)(282,000)(739,000)
Income Before Tax -   -   -   -  
Income Tax Expense7,022,000  8,456,000  3,132,000  1,286,000  
Minority Interest(7,375,000)(4,863,000)(3,855,000)(913,000)
Net Income From Continuing Ops38,809,000  34,759,000  30,433,000  19,106,000  
Non-recurring Events
Discontinued Operations(19,000)(65,000)(11,000)(32,000)
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 31,415,000   29,831,000   26,567,000   18,161,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in INR.